SCHEMBL26569652

SCHEMBL26569652

Cc1nc(C)c(C(C)(C)C)cc1-c1nc(C(C)(C)C)nc(C(C)(C)C)n1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26569655 0.69 PSMB5 (0.50)
SCHEMBL26569683 0.69 SMN1; SMN2 (0.38)
SCHEMBL26569654 0.68 KIF11 (0.42)
SCHEMBL14867639 0.68 CYP2C19 (0.38)
SCHEMBL26569653 0.66 PSMB5 (0.33)
SCHEMBL25817341 0.65 GAA (0.38)
SCHEMBL23872363 0.64 ALDH1A1 (0.34)
SCHEMBL20457096 0.64 SMN1; SMN2 (0.41)
SCHEMBL24732472 0.64 KDM4E (0.37)
SCHEMBL18073610 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337517-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337517-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LBR, OCIAD2, OCIAD1 HSP90AA1 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.